Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)
 

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

on

  • 2,112 views

 

Statistics

Views

Total Views
2,112
Views on SlideShare
2,112
Embed Views
0

Actions

Likes
0
Downloads
57
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) Document Transcript

  •    Get more info on this report!Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends inEgypt, Jordan, Israel, Saudi Arabia and UAE)November 1, 2008At present the Middle East region constitutes as small percent of global pharmaceuticalsales. However, ever-increasing populations and governmental healthcare reforms arelikely to increase demand. These markets will be essential for pharmaceuticalscompanies exploring new opportunities for growth. Developing regions will be anintegral part of expansion for companies looking to capture a larger portion of theworldwide market.This Kalorama Information report, Pharmaceutical Markets in the Middle East(Opportunities, Key Players, Trends) takes a thorough look at the emerging markets inthese countries: • Egypt • United Arab Emirates • Isreal • Saudi Arabia • JordanAs part of its exhuastive coverage, for each countrys market, the report includes: • Current Pharmaceutical Market Size • Market Forecast • Regulatory Environment • Economic Statistics • Disease and Health Spending Statistics • Leading Pharmaceutical SuppliersIn addition, trends that apply to all countries such as generic competition, regulatorymatters, Companies profiled in this report include:
  • • Banaja • Dar Al Dawa • GlaxoSmithKline Egypt • Gulf Pharmaceutical Industries • Hikma Pharmaceuticals • Medical Union Pharmaceutical Company • Perrigo Israel • Pharco Pharmaceuticals • Saudi Pharmaceutical Industries & Medical Appliances Corp. • TEVAThe information for this report was gathered using both primary and secondary researchincluding comprehensive research of secondary sources such as company literature,databases, investment reports, and medical and business journals. Telephoneinterviews and email correspondence were the primary method of gathering information.For the purpose of this study, Kalorama Information conducted interviews with morethan 30 key industry officials, consultants, health care providers, and governmentpersonnel. These sources were the primary basis in gathering information specificallyrelating to revenue and market share data presented in this report. Additional interviewswere completed with relevant company representatives including marketing directors,division managers, and product representatives.All market data pertains to the world market at the manufacturers’ level. The base yearfor data was 2007. Historical data was provided for the years 2005 and 2006, withforecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs)are provided for the 2005-2007 and 2008-2012 periods for each region and/or segmentcovered. The forecasted market analysis for 2008-2012 was largely based ondemographic trends, new developments, and global expansion.Table of ContentsCHAPTER ONE: EXECUTIVE SUMMARY • Overview • Scope and Methodology • Size and Growth of the Market • Key Issues and Trends Affecting the Market • Leading CompetitorsCHAPTER TWO: INTRODUCTION • Overview • Intellectual Property Rights and Compulsory Licensing • Biosimilar Production
  • • World Health • Tobacco Use • ObesityCHAPTER THREE: PHARMACEUTICAL MARKETS IN ISRAEL • Overview and Summary • Regulatory Environment • Intellectual Property Rights • Economic Development • GDP and Healthcare Spending • Healthcare Trends in Israel • Demographics o Birth Rates o Life Expectancy o Mortality • Key Product Segments and Market Indicators o Cardiovascular Disease o Infection Control Disease o Central Nervous System Drugs o Oncology • Market Analysis • Sales of Pharmaceuticals by Generic Supply • Leading Pharmaceutical SuppliersCHAPTER FOUR: PHARMACEUTICAL MARKETS IN EGYPT • Overview and Summary • Regulatory Environment • Economic Development • GDP and Healthcare Spending • Healthcare Trends in Egypt • Demographics • Birth Rates • Life Expectancy • Mortality • Key Product Segments and Market Indicators • Cardiovascular Disease • Infection Control • Oncology • Diabetes • Market Analysis • Sales of Pharmaceuticals by Generic Supply • Leading Pharmaceutical SuppliersCHAPTER FIVE: PHARMACEUTICAL MARKETS IN SAUDI ARABIA View slide
  • • Overview and Summary • Regulatory Environment • Intellectual Property Rights • Economic Development • GDP and Healthcare Spending • Healthcare Trends in Saudi Arabia • Demographics • Birth Rates • Life Expectancy • Mortality • Key Product Segments and Market Indicators • Cardiovascular Disease • Infection Control • Oncology • Diabetes and Other Diseases • Market Analysis • Sales of Pharmaceuticals by Generic Supply • Leading Pharmaceutical SuppliersCHAPTER SIX: PHARMACEUTICAL MARKETS IN JORDAN • Overview and Summary • Regulatory Environment • Intellectual Property Rights • Economic Development • GDP and Healthcare Spending • Healthcare Trends in Jordan • Jordanian Insurance Coverage • Demographics • Birth Rates • Life Expectancy • Mortality • Key Product Segments and Market Indicators • Cardiovascular Disease • Infection Control • Oncology • Diabetes • Market Analysis • Sales of Pharmaceuticals by Generic Supply • Leading Pharmaceutical SuppliersCHAPTER SEVEN: PHARMACEUTICAL MARKETS IN THE UNITED ARABEMIRATES • Overview and Summary • Regulatory Environment View slide
  • • Intellectual Property Rights • Economic Development • GDP and Healthcare Spending • Healthcare Trends in the UAE • Demographics • Birth Rates • Life Expectancy • Mortality • Key Product Segments and Market Indicators • Cardiovascular Disease • Infection Control • Oncology • Diabetes • Market Analysis • Sales of Pharmaceuticals by Generic Supply • Leading Pharmaceutical SuppliersCHAPTER SEVEN: MARKET SUMMARY • OverviewCHAPTER EIGHT: LEADING PHARMACEUTICAL PROVIDERS IN THE MIDDLEEAST • Overview • Banaja • Dar Al Dawa • GlaxoSmithKline Egypt • Gulf Pharmaceutical Industries (Julphar) • Hikma Pharmaceuticals • Medical Union Pharmaceutical Company • Perrigo Israel • Pharco Pharmaceuticals • Saudi Pharmaceutical Industries & Medical Appliances Corporation • TEVAAPPENDIX: LIST OF MAJOR COMPANIESLIST OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARY • Figure 1-1: Middle East Market Analysis: 2005-201CHAPTER THREE: PHARMACEUTICAL MARKETS IN ISRAEL
  • • Table 3-1: Israel’s Economic Sectors • Table 3-2: Israel’s GDP and Healthcare Spending • Table 3-3: Israel - Midyear Population, by Age and Sex, 2007 and 2012 • Figure 3-1: Israel - Midyear Population, by Age, 2007 and 2012 • Table 3-4: Israel Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 • Figure 3-2: Israel Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 • Table 3-5: Israel Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 • Figure 3-3: Israel Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 • Table 3-6: Israel Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015 • Figure 3-4: Israel Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015 • Table 3-7: Tuberculosis Surveillance and Epidemiology, Israel • Table 3-8: Israel Pharmaceutical Market Analysis, 2005-2007 • Table 3-9: Israel Pharmaceutical Market Analysis: 2008-2012 • Figure 3-5: Israel Pharmaceutical Market Analysis: 2005-2012 • Table 3-10: Estimated Sales of Pharmaceuticals in Israel by Generic Or Brand, 2007 • Figure 3-6: Estimated Sales of Pharmaceuticals in Israel by Generic Or Brand, 2007CHAPTER FOUR: PHARMACEUTICAL MARKETS IN EGYPT • Table 4-1: Egypt’s Economic Sectors • Table 4-2: Egypt’s GDP and Healthcare Spending • Table 4-3: Egypt - Midyear Population, by Age and Sex, 2007 and 2012 • Figure 4-1: Egypt - Midyear Population, by Age, 2007 and 2012 • Table 4-4: Egypt Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 • Figure 4-2: Egypt Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 • Table 4-5: Egypt Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 • Figure 4-3: Egypt Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 • Table 4-6: Egypt Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 • Figure 4-4: Egypt Mortality Rates and Numbers: Estimated 2000, 2005; Projected 2010, 2015 • Table 4-7: Tuberculosis Surveillance and Epidemiology, Egypt • Table 4-8: Egypt Pharmaceutical Market Analysis, 2005-2007 • Table 4-9: Egypt Pharmaceutical Market Analysis: 2008-2012
  • • Figure 4-5: Egypt Pharmaceutical Market Analysis: 2005-2012 • Table 4-10: Estimated Sales of Pharmaceuticals in Egypt by Generic Or Brand, 2007 • Figure 4-6: Estimated Sales of Pharmaceuticals in Egypt by Generic Or Brand, 2007CHAPTER FIVE: PHARMACEUTICAL MARKETS IN SAUDI ARABIA • Table 5-1: Saudi Arabia’s Economic Sectors • Table 5-2: Saudi Arabia’s GDP and Healthcare Spending • Table 5-3: Saudi Arabia - Midyear Population, by Age and Sex, 2007 and 2012 • Figure 5-1: Saudi Arabia - Midyear Population, by Age, 2007 and 2012 • Table 5-4, Saudi Arabia Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 • Figure 5-2: Saudi Arabia Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 • Table 5-5: Saudi Arabia Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 • Figure 5-3: Saudi Arabia Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 • Table 5-6: Saudi Arabia Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015 • Figure 5-4: Saudi Arabia Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 • Table 5-7: Tuberculosis Surveillance and Epidemiology, Saudi Arabia • Table 5-8: Saudi Arabia Cancer Incidence in Men and Women 2006 • Table 5-9: Saudi Arabia Pharmaceutical Market Analysis, 2005-2007 • Table 5-10: Saudi Arabia Pharmaceutical Market Analysis: 2008-2012 • Figure 5-4: Saudi Arabia Pharmaceutical Market Analysis: 2005-2012 • Table 5-11: Estimated Sales of Pharmaceuticals in Saudi Arabia by Generic Or Brand, 2007 • Figure 5-5: Estimated Sales of Pharmaceuticals in Saudi Arabia by Generic Or Brand, 2007CHAPTER SIX: PHARMACEUTICAL MARKETS IN JORDAN • Table 6-1: Jordan’s Economic Sectors • Table 6-2: Jordan’s GDP and Healthcare Spending • Table 6-3: Jordan - Midyear Population, by Age and Sex, 2007 and 2012 • Figure 6-1: Jordan - Midyear Population, by Age, 2007 and 2012 • Table 6-4: Jordan Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 • Figure 6-2: Jordan Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 • Table 6-5: Jordan Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020
  • • Figure 6-3L Jordan Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 • Table 6-6: Jordan Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 • Figure 6-4: Jordan Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 • Table 6-7: Tuberculosis Surveillance and Epidemiology, Jordan • Table 6-8: Jordan Pharmaceutical Market Analysis, 2005-2007 • Table 6-9: Jordan Pharmaceutical Market Analysis: 2008-2012 • Figure 6-5: Jordan Pharmaceutical Market Analysis: 2005-2012 • Table 6-10: Estimated Sales of Pharmaceuticals in Jordan by Generic Or Brand, 2007 • Figure 6-6: Estimated Sales of Pharmaceuticals in Jordan by Generic Or Brand, 2007CHAPTER SEVEN: PHARMACEUTICAL MARKETS IN THE UNITED ARABEMIRATES • Table 7-1: United Arab Emirates’ Economic Sectors • Table 7-2: United Arab Emirates’ GDP and Healthcare Spending • Table 7-3: UAE - Midyear Population, by Age and Sex, 2007 and 2012 • Figure 7-1: UAE - Midyear Population, by Age, 2007 and 2012 • Table 7-4: UAE Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 • Figure 7-2: UAE Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 • Table 7-5: UAE Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 • Figure 7-3: UAE Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 • Table 7-6: UAE Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 • Figure 7-4: UAE Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 • Table 7-7: UAE Pharmaceutical Market Analysis, 2005-2007 • Table 7-8: UAE Pharmaceutical Market Analysis: 2008-2012 • Figure 7-5: UAE Pharmaceutical Market Analysis: 2005-2012 • Table 7-9: Estimated Sales of Pharmaceuticals in UAE by Generic Supply, 2007 • Figure 7-6: Estimated Sales of Pharmaceuticals in UAE by Generic Or Brand, 2007CHAPTER EIGHT: MARKET SUMMARY • Table 8-1: Pharmaceutical Markets in the Middle East: Market Analysis, 2005- 2007
  • • Table 8-2: Pharmaceutical Markets in the Middle East: Market Analysis: 2008- 2012 • Figure 8-1: Pharmaceutical Markets in the Middle East: Market Analysis: 2005- 2012 • Table 8-3: Middle East Pharmaceutical Markets by Country, 2007 • Figure 8-2: Middle East Pharmaceutical Markets by Country, 2007Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=1646593  US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004